Literature DB >> 749182

[Histopathology of bone lesions in 9 cases of algodystrophy of the hip].

J Arlet, P Ficat, R Durroux, J P Theallier, B Mazières, G Bouteiller.   

Abstract

The authors present the results of histo-pathological observations made in 9 cases of sympatic algodystrophy reflex of the hip, subjected to a punch biopsy of the head and neck of the femur. The punch biopsy was decided upon, either because of difficult diagnosis, or because of the abnormally long duration of the pain syndrome. In all cases, there were bone lesions. The most common were in the marrow tissue, with stasis (9 cases), fibrosis (7 cases) and necrosis at small, isolated points (5 cases). There was osteoclastic resorption in the bones in 3 cases, and rapid osteogenesis in 6 cases. The latter anomaly revealed the rapid reconstruction characterizing the syndrome. Finally, the authors comment on the relationship between algodystrophy and necrosis of the hip, and the advantages of punch biopsy.

Entities:  

Mesh:

Year:  1978        PMID: 749182

Source DB:  PubMed          Journal:  Rev Rhum Mal Osteoartic        ISSN: 0035-2659


  4 in total

1.  Calcitonin and reflex sympathetic dystrophy syndrome.

Authors:  C Gobelet; J L Meier; W Schaffner; A Bischof-Delaloye; J C Gerster; P Burckhardt
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

2.  Histopathology of the vessels of the femoral heads in specimens of osteonecrosis, osteoarthritis and algodystrophy.

Authors:  J Arlet; M Laroche; R Soler; M Thiechart; M T Pieraggi; B Mazières
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

3.  Osteonecrosis of the femoral head and pregnancy.

Authors:  J Arlet; B Mazieres; C Netry
Journal:  Clin Rheumatol       Date:  1982-06       Impact factor: 2.980

4.  Influence of calcitonin treatment on the osteocalcin concentration in the algodystrophy of bone.

Authors:  A Sawicki; P Szulc; T Sobczyk; J Goliszewski; P Garnier; R Labuszewski
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.